Showing 141-150 of 904 results for "".
Spot Rosacea Mimickers that Can Complicate Diagnosis and Treatment
https://practicaldermatology.com/topics/general-topics/spot-rosacea-mimickers-that-can-complicate-diagnosis-and-treatment/21705/Dermatologists are generally adept at diagnosing the various “red face” conditions, but sometimes mimickers are mistaken for rosaceaResolution of Primary Erythromelalgia Following Ibuprofen; Fire Power
https://practicaldermatology.com/youngmd-connect/resident-resource-center/resolution-of-primary-erythromelalgia-following-ibuprofen-fire-power/20619/Gene Biomarker Research and Implications for Care
https://practicaldermatology.com/topics/psoriasis/gene-biomarker-research-and-implications-for-care/23374/A tape strip test can differentiate psoriasis from atopic dermatitis based on genetic analysis. How may the finding affect care?Open Payments Program: Does it Enhance Open Discussion About Financial Ties Between Dermatologists and Industry?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/open-payments-program-does-it-enhance-open-discussion-about-financial-ties-between-dermatologists-and-industry/23619/The majority of physicians practicing in the United States have received some form of compensation from private industry during their careers. These payments may include consulting fees, compensation for speaking engagements, and stock options. Certain payments take indirect forms, such as physicAtopic Dermatitis: A Review of Common Comorbidities
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-a-review-of-common-comorbidities/23352/It is important to acknowledge and identify comorbidities to successfully manage AD and improve patient quality of life.Evolution in Dermatology/Industry Partnerships
https://practicaldermatology.com/topics/practice-management/evolution-in-dermatologyindustry-partnerships/23295/The COVID-19 crisis is changing the dermatology industry. What does it mean?What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis
https://practicaldermatology.com/topics/psoriasis/what-does-efficacy-cost-evidence-for-relative-cost-effectiveness-of-biologic-therapies-for-psoriasis/23128/Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.Psoriasis in Sensitive Areas
https://practicaldermatology.com/topics/psoriasis/psoriasis-in-sensitive-areas/23868/Treatment updates and tips for communicating with patients.Topical Psoriasis Therapies: An Update
https://practicaldermatology.com/topics/psoriasis/topical-psoriasis-therapies-an-update/23009/The latest research offers insights on the benefits and utility of topical treatment.Colloidal Oat Wash Helps Infants with AD-prone Skin
https://practicaldermatology.com/issues/novemberdecember-2025/colloidal-oat-wash-helps-infants-with-ad-prone-skin/48896/As parents and pediatricians seek safe, science-backed skin care options for infants with atopic dermatitis (AD)-prone or reactive skin, a recent study offers clinical support for using a colloidal oat-based baby wash in the bath routine.